Search Results 251-260 of 17340 for meningococcal vaccine
A natural Haemophilus influenzae type b (Hib) infection could result in permanent brain damage. Vaccination can help prevent these diseases and their ...
The purpose of this clinical study is to assess the safety and effectiveness of the immunotherapeutic product GSK 2302032A when given to Non-Small Cell Lung ...
Additional doses should be given a minimum of 28 days after completing a messenger RNA vaccination series. The Moderna and Pfizer COVID-19 vaccines are ...
Mayo Clinic's Vaccine Research Group will begin work on developing a vaccine to protect against the Zika virus, according to Mayo vaccinologist Gregory ...
The purpose of this study is to determine how safe and how well POL-103A works in preventing the relapse of melanoma after patients who have undergone surgery.
Learn about how the Virology, Vector and Vaccine Engineering Laboratory of Michael A. Barry, Ph.D., at Mayo Clinic applies metabolic biotinylation to vector ...
Learn about cell-targeting by optical imaging in the Virology, Vector and Vaccine Engineering Laboratory of Michael A. Barry, Ph.D., at Mayo Clinic.
About 85% of all people will become infected at some point in their lifetime. "Thankfully, we have a great vaccine. The. HPV vaccine can prevent 90% of cancers.
This makes passive immunization very effective for those who are immunocompromised, or can't respond to a vaccine or an infection with immunity. Convalescent ...
By systematically reviewing patient records, confirming vaccination status, and engaging in structured discussions with eligible unvaccinated patients, we seek ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.